2006 HCPCS Q0179
For use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen ondansetron hydrochloride 8 mg, oral, fda approved prescription anti-emetic,

  • This is the 2006 version of HCPCS Q0179 - please refer to the 2016 HCPCS code set for the latest version.

  Q0178    Q0180